Terms & Conditions — Medharvix Systems Private Limited

Last updated: May 2026

1. Introduction

These Terms & Conditions (“Terms”) govern access to and use of the website, products, model interfaces, published materials, communications, and related services operated by Medharvix Systems Private Limited (“Medharvix,” “we,” “our,” or “us”), a company incorporated under the laws of India.

By accessing or using this website, or by engaging with Medharvix in any professional, research, or commercial capacity, you acknowledge that you have read, understood, and agree to be bound by these Terms. If you do not agree, you must discontinue use of the website and related services immediately.

2. Use of the Website

The Medharvix website may only be used for lawful purposes and in a manner consistent with these Terms and all applicable laws and regulations.

You agree not to:

Attempt to gain unauthorised access to any portion of the website, servers, systems, or databases;
Use automated tools, scrapers, bots, or crawlers to extract, copy, or index website content without prior written permission;
Introduce malicious code, interfere with website functionality, or disrupt the experience of other users;
Use the website for any fraudulent, abusive, harassing, or otherwise unlawful purpose;
Misrepresent your identity, affiliation, or the purpose of your engagement with Medharvix.

3. Intellectual Property

All content on this website — including but not limited to text, graphics, branding, logos, layouts, product names, model descriptions, technical documentation, research materials, training methodologies, architectural details, user interface designs, and related digital assets — is the property of or is licensed to Medharvix Systems Private Limited, unless explicitly stated otherwise.

No content may be copied, reproduced, republished, redistributed, reverse-engineered, scraped, decompiled, or commercially exploited in any form without the prior written consent of Medharvix.

All rights not expressly granted herein are reserved by Medharvix Systems Private Limited.

4. Product, Model, and Research Use

Demonstrations, previews, product descriptions, research summaries, benchmark results, roadmap references, and technical specifications published on this website are provided for informational purposes only unless otherwise agreed in a separate written agreement.

Specific products, datasets, models, APIs, code repositories, or research artifacts developed by Medharvix may be governed by separate licence agreements, access terms, data use agreements, or project-specific contracts. Users must refer to the applicable licence or agreement before use.

Without the prior written approval of Medharvix, users may not:

Conduct unauthorised benchmarking or performance testing of Medharvix models or systems;
Attempt to extract, distil, replicate, or reconstruct proprietary model weights, architectures, or training methods;
Copy, adapt, or derive from Medharvix workflows, pipelines, or evaluation methodologies for competitive purposes;
Use any Medharvix output, dataset, or research material for purposes beyond the scope of any applicable agreement.

5. Confidentiality

Certain information shared by or on behalf of Medharvix — whether in the course of business discussions, partnerships, collaborations, evaluations, demonstrations, or project engagements — may be confidential, proprietary, restricted, or commercially sensitive in nature.

Such information includes, without limitation:

Datasets, annotation guidelines, evaluation files, and data processing methodologies;
Prompts, model outputs, inference configurations, and fine-tuning strategies;
Source materials, training corpora, and linguistic resources;
Technical documentation, system architectures, and internal specifications;
Product roadmaps, business strategies, and commercial terms;
Project discussions, deliverables, and internal communications.

Any person or entity receiving confidential information from Medharvix must:

Keep such information strictly confidential and protect it using reasonable safeguards;
Use the information solely for the authorised purpose for which it was disclosed;
Not disclose, distribute, or make available such information to any third party without prior written consent;
Restrict access to authorised personnel on a strict need-to-know basis;
Not store, transfer, publish, copy, or reuse confidential information in any unauthorised environment or system;
Return or destroy all confidential materials upon request, where applicable and feasible.

6. Government and Institutional Project Confidentiality

Medharvix may work on, participate in, or contribute to projects involving government bodies, public institutions, universities, strategic partners, regulated entities, or other sensitive operational environments.

Any information, dataset, documentation, workflow, benchmark, communication, deliverable, or technical material related to such projects may be subject to strict confidentiality and restricted handling obligations that exceed the general terms outlined above.

Any person engaged with Medharvix in any capacity — including but not limited to collaborators, contractors, consultants, interns, researchers, annotators, vendors, evaluators, or service providers — must not access, copy, disclose, retain, transfer, publish, or reuse any restricted or project-related data except where:

Explicitly authorised in writing by an authorised representative of Medharvix;
Strictly necessary for the approved and documented scope of work;
Conducted in compliance with all applicable security, privacy, and data handling requirements.

Sensitive datasets used in the context of such projects must remain confidential at all times. Unauthorised access, retention, or disclosure of such data constitutes a material breach of these Terms and may give rise to legal action.

Where applicable, separate Non-Disclosure Agreements (NDAs), project contracts, data security instructions, or project-specific legal agreements may be required. In the event of any conflict between these Terms and a project-specific agreement, the project-specific agreement shall prevail.

7. User Responsibilities

Users engaging with Medharvix — whether through the website, email, forms, or any other communication channel — must:

Provide accurate, truthful, and lawful information;
Not submit malicious content, unlawful material, misleading claims, or unsolicited commercial communications;
Not disclose third-party confidential information to Medharvix without proper authority to do so;
Ensure that their conduct complies with all applicable local, national, and international laws and obligations.

8. Third-Party Links and Platforms

The Medharvix website may contain links to third-party websites, repositories, demonstrations, hosting platforms, research pages, or external tools. These links are provided for convenience and informational purposes only.

Medharvix is not responsible for the content, accuracy, availability, privacy practices, or security of any third-party website or platform. Use of third-party services is governed entirely by the terms, conditions, and privacy policies of those respective platforms.

9. No Warranties

The Medharvix website and all materials published on it are provided on an “as is” and “as available” basis, unless otherwise expressly stated in a separate written agreement.

Medharvix does not warrant or guarantee:

Uninterrupted, error-free, or secure access to the website;
The completeness, accuracy, or currency of any content or information;
The suitability of any product, model, or research output for a specific use case, deployment, or regulatory context.

10. Limitation of Liability

To the maximum extent permitted by applicable law, Medharvix Systems Private Limited, its directors, officers, employees, affiliates, and agents shall not be liable for any indirect, incidental, consequential, special, reputational, commercial, or data-related losses arising from or in connection with:

Use of, or inability to use, the website or any related services;
Reliance on any information, content, or materials published on the website;
Use of third-party platforms, tools, or services linked from the website;
Unauthorised access to, or alteration of, user data or communications.

11. Suspension or Termination

Medharvix reserves the right, at its sole discretion and without prior notice, to restrict, suspend, or terminate access to the website, demonstrations, shared materials, or any project-related interactions in the event of:

Suspected or confirmed misuse of the website or Medharvix services;
Unauthorised disclosure of confidential or restricted information;
Infringement of intellectual property rights;
Breach of these Terms or any applicable agreement;
Security risks or threats to the integrity of Medharvix systems or data.

12. Changes to the Terms

Medharvix may update, amend, or revise these Terms & Conditions from time to time at its discretion. Any material changes will be reflected by an updated “Last updated” date at the top of this page.

Continued use of the Medharvix website after the publication of revised Terms constitutes your acceptance of the updated Terms.

13. Governing Law

These Terms & Conditions shall be governed by and construed in accordance with the laws of India. Any disputes arising under or in connection with these Terms shall be subject to the exclusive jurisdiction of the courts of competent authority in Gurugram, Haryana, India, unless otherwise specified by applicable project-specific legal agreements.

14. Contact

For any questions, concerns, or requests related to these Terms & Conditions, please contact:

Medharvix Systems Private Limited
Signature Global Prime, Tower B, Sector 63A
Gurugram, Haryana 122102, India
Email: contact@medharvix.com
Phone: +91 82106 80104